AI / data analytics / healthtech / informatics

PanHunter
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Case study #Evotec #Machine learning #Multi-omics #Omics #Software

Case study: The PanHunter multi-omics analysis platform

A new Case Study is available, sponsored by Evotec. The study of health and disease through multi-omics research generates vast amounts of interconnected data. Unlocking their secrets requires complex bioinformatic exploration. This analysis is accelerated by a dedicated and flexible software application that is not only reliable and provides… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Machine learning #Multi-omics #Omics #Software

PanHunter: Your enterprise solution to find the detail that matters

The study of health and disease through multi-omics research generates vast amounts of interconnected data. Unlocking their secrets requires complex bioinformatic exploration. This analysis is accelerated by a dedicated and flexible software application that is not only reliable and provides reproducible results, but also facilitates collaboration between project investigators… Read More

#Resources

#AI / data analytics / healthtech / informatics #Cryo-EM #Curreio #Iktos #Partnership

Drug discovery agreement will combine AI and cryo-EM analysis

As part of a new collaboration, Iktos’ generative design technology and Curreio’s cryo-electron microscopy (cryo-EM) platform will be combined to design novel preclinical drug candidates for an undisclosed target. Iktos’ Makya generative AI technology aims to bring new insights and directions into the molecular discovery process… Read More

#News

FDA
#AI / data analytics / healthtech / informatics #Clinical trial design #Clinical trials #Digitalisation #FDA

FDA announces additional steps to modernise clinical trials

The US Food and Drug Administration has published draft guidance with updated recommendations for good clinical practices (GCPs) to modernise the design and conduct of clinical trials. The updates are intended to help pave the way for more efficient clinical trials. The draft guidance is adopted from the International Council… Read More

#Editor's Choice #News #Regulatory

Automation and robotics
#AI / data analytics / healthtech / informatics #Automated liquid handling #Automation / robotics #Lab automation #Opentrons

Open-source lab robot makes bioautomation accessible for all

Lab automation company Opentrons has launched the Opentrons Flex robot. The company says that these are affordable and easy-to-programme liquid-handling lab robots which are designed to level the playing field for labs of all sizes and bring advanced lab automation to more researchers. Fusing advanced robotics… Read More

#News

Artificial intelligence
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Benchling #Cancer research #Drug discovery #Machine learning #Rare disease

Latest eBook: AI and drug development

The latest eBook by DDW is out now. This 28-page eBook, sponsored by Benchling, examines the ways in which artificial intelligence and machine learning are expediting drug discovery efforts. Download this exclusive eBook to learn more about: The latest advancements in artificial intelligence… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Benchling #Cancer research #Drug discovery #Machine learning #Rare disease

AI and drug development: Using AI and machine learning to expedite drug discovery

This latest eBook sponsored by Benchling features insight on how artificial intelligence is helping advance drug discovery efforts. Download this exclusive eBook to learn more about: The latest advancements in artificial intelligence How machine learning is being used across cancer research Why AI is critical to solving challenges in drug… Read More

#DDW eBooks #Intelligence

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Benchling #Data standardisation #Machine learning

Want to be ready to implement AI and ML in biotech? Start with your data

This article is sponsored by Benchling. “What’s the single most important factor when building a machine learning model? Data! Having the right data, and an understanding of the uncertainty in that data often makes the difference between useful and useless models,” said Pat Walters, Chief Data… Read More

#News

AI
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Biochemistry #Molecular Biology

AI provides new insight into preventing human disease

A molecular machine, which plays an essential ‘cargo’ role in controlling the delivery of proteins to the surface of human cells has been identified using artificial intelligence (AI). The research has shown how manipulating this process could treat or prevent disease, with implications for SARS-CoV-2, human… Read More

#News

AI brain
#AI / data analytics / healthtech / informatics #Drug discovery #Funding #MultiOmic Health #Precision medicine #Seed funding #Start-ups

AI platform focuses on precision medicines for metabolic syndromes

AI drug discovery company MultiOmic Health has closed a £5 million ($6.2 million) seed funding extension round to build a precision therapeutics discovery platform for metabolic syndrome-related medical conditions. The round was led by London-based Hoxton Ventures, with participation from Ada Ventures, MMC Ventures and Verve… Read More

#News #Start-up Zone

Artificial intelligence
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Drug targets #Machine learning

Can artificial intelligence help craft new medicines?

Listen to this article on the DDW Podcast: Professor Sonika Bhatnagar explores how artificial intelligence is enabling drug discovery at rates never seen before. A bullet for cure The year was 1907, and Paul Ehrlich, the German Nobel laureate had proposed the idea of a magic bullet to cure diseases. The magic… Read More

#Exclusive Content

#Absci #AI / data analytics / healthtech / informatics #Antibodies #Artificial intelligence (AI) #Drug discovery #Interview

How generative AI could improve drug discovery

Listen to this article on the DDW Podcast: Absci is a generative artificial intelligence (AI) drug creation company with goals of bringing better biologics to patients more quickly. Here, DDW Editor Reece Armstrong speaks to Sean McClain, the Founder and CEO of Absci about how generative AI is being used within… Read More

#Exclusive Content

Test for AMD
#AI / data analytics / healthtech / informatics #Boehringer Ingelheim #Collaboration #Geographic atrophy #Partnership #RetinaAI

Partners use AI tools to advance novel drugs for geographic atrophy

A partnership between RetinAI Medical and Boehringer Ingelheim aims to improve patient outcomes in geographic atrophy (GA) by combining RetinAI’s Discovery platform and AI tools with Boehringer Ingelheim’s research in retinal diseases. GA is a progressive, advanced form of age-related macular degeneration and a leading cause of complete loss of… Read More

#Business & Investment #News

#AI / data analytics / healthtech / informatics #Automation / robotics #Europe #Events #High throughput screening #Lab automation #SLAS Europe

What to expect from SLAS Europe 2023

SLAS Europe 2023 will take place 22-26 May in Brussels, Belgium, where attendees will embrace the theme Science Set in Motion. DDW’s Multimedia Editor Megan Thomas explores what to expect from the event. Scientific tracks SLAS Europe 2023 will feature four tracks focused on life sciences and their global impact:… Read More

#Exclusive Content

Histology slides
#AACR 2023 #AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Cancer research #Machine learning #Oncology

AI can predict the risk of distant recurrence in endometrial cancer

An investigational deep learning model requiring one histopathologic slide accurately predicted the risk of distant recurrence in patients with endometrial cancer, according to findings presented at the AACR Annual Meeting 2023. Endometrial cancer is the most common type of uterine cancer. While patients with early-stage uterine… Read More

#Cancer Research #News #Trending News

#AI / data analytics / healthtech / informatics #Automation #Data automation #Data management #Digitalisation #Drug discovery

Accelerating time to market through digitalisation

Listen to this article on the DDW Podcast: Sascha Fischer Business Development Manager for Automation at Genedata looks at three critical digitalisation components that enable end-to-end lab automation, improve the return on investment (ROI) on instrumentation investments and streamline time-to-market.  Heightened regulatory demands, increasingly competitive markets, more challenging emergency medical needs,… Read More

#Exclusive Content